Alterations in the contractile phenotype of the bladder: Lessons for understanding physiological and pathological remodelling of smooth muscle

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 2, 2012, Pages 203-217

  Zderic, Stephen A ^a   Chacko, Samuel ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bladder; Hypertrophy; Myosin; Outlet obstruction; Remodelling; Smooth muscle

Indexed keywords

MYOSIN LIGHT CHAIN; OLIGOPEPTIDE;

ANIMAL; BLADDER; BLADDER OBSTRUCTION; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; HUMAN; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; RABBIT; REVIEW; SMOOTH MUSCLE;

ANIMALS; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSIN LIGHT CHAINS; OLIGOPEPTIDES; RABBITS; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION;

ANIMALIA;

EID: 84856341761     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01368.x     Document Type: Review

References (86)

1. Litwin MS, Saigal CS. Urologic diseases in America: NIH, NIDDK. Washington, DC : US Government Printing Office; 2007.
2. Rolle U, Puri P. Structural basis of voiding dysfunction in megacystis microcolon intestinal hypoperistalsis syndrome. J Pediatr Urol. 2006; 2: 277-84.
3. MacLeod M, Kelly R, Robb SA, et al Bladder dysfunction in Duchenne muscular dystrophy. Arch Dis Child. 2003; 88: 347-9.
4. Hsu TH, Levin RM, Wein AJ, et al Alterations of mitochondrial oxidative metabolism in rabbit urinary bladder after partial outlet obstruction. Mol Cell Biochem. 1994; 141: 21-6.
5. Nevel-McGarvey CA, Rohrmann D, Levin RM, et al Mitochondrial and mitochondrial-related nuclear genetic function in rabbit urinary bladder following reversal of outlet obstruction. Mol Cell Biochem. 1999; 197: 161-72.
6. Garcia-Velasco A, Gomez-Escalonilla C, Guerra-Vales JM, et al Intestinal pseudo-obstruction and urinary retention: cardinal features of a mitochondrial DNA-related disease. J Intern Med. 2003; 253: 381-5.
7. Sillen U, Bachelard M, Hermanson G, et al Gross bilateral reflux in infants: gradual decrease of initial detrusor hypercontractility. J Urol. 1996; 155: 668-72.
8. Sillen U. Bladder function in infants. Scand J Urol Nephrol Suppl. 2004; 215: 69-74.
9. Sillen U, Bachelard M, Hansson S, et al Video cystometric recording of dilating reflux in infancy. J Urol. 1996; 155: 1711-5.
10. Keating MA, Duckett JW, Snyder HM, et al Ontogeny of bladder function in the rabbit. J Urol. 1990; 144: 766-9.
11. Zderic SA, Hypolite J, Duckett JW, et al Developmental aspects of bladder contractile function: sensitivity to extracellular calcium. Pharmacology. 1991; 43: 61-8.
12. Zderic SA, Sillen U, Liu GH, et al Developmental aspects of bladder contractile function: evidence for an intracellular calcium pool. J Urol. 1993; 150: 623-5.
13. Zderic SA, Sillen U, Liu GH, et al Developmental aspects of excitation contraction coupling of rabbit bladder smooth muscle. J Urol. 1994; 152: 679-81.
14. Gong C, Zderic SA, Levin RM. Ontogeny of the ryanodine receptor in rabbit urinary bladder smooth muscle. Mol Cell Biochem. 1994; 137: 169-72.
15. Zderic SA, Gong C, Hypolite J, et al Developmental aspects of excitation contraction coupling in urinary bladder smooth muscle. Adv Exp Med Biol. 1995; 385: 105-15.
16. Wu HY, Zderic SA, Wein AJ, et al Decrease in maximal force generation in the neonatal mouse bladder corresponds to shift in myosin heavy chain isoform composition. J Urol. 2004; 171: 841-4.
17. Lin VK, Robertson JB, Lee IL, et al Smooth muscle myosin heavy chains are developmentally regulated in the rabbit bladder. J Urol. 2000; 164: 1376-80.
18. Kuro-o M, Nagai R, Tsuchimochi H, et al Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem. 1989; 264: 18272-5.
19. 2+ sensitivity, and myosin light chain phosphorylation in urinary bladder smooth muscle of newborn mice. J Gen Physiol. 2005; 125: 187-96.
20. Burnett AL, Calvin DC, Chamness SL, et al Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nat Med. 1997; 3: 571-4.
21. Huang PL, Dawson TM, Bredt DS, et al Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993; 75: 1273-86.
22. Sutherland RS, Kogan BA, Piechota HJ, et al Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. J Urol. 1997; 157: 1109-16.
23. Stein R, Gong C, Hutcheson JC, et al The decompensated detrusor III: impact of bladder outlet obstruction on sarcoplasmic endoplasmic reticulum protein and gene expression. J Urol. 2000; 164: 1026-30.
24. Zderic SA, Rohrmann D, Gong C, et al The decompensated detrusor II: evidence for loss of sarcoplasmic reticulum function after bladder outlet obstruction in the rabbit. J Urol. 1996; 156: 587-92.
25. Lassmann J, Sliwoski J, Chang A, et al Deletion of one SERCA2 allele confers protection against bladder wall hypertrophy in a murine model of partial bladder outlet obstruction. Am J Physiol Regul Integr Comp Physiol. 2008; 294: R58-65.
26. 2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem. 1999; 274: 2556-62.
27. Schultz Jel J, Glascock BJ, Witt SA, et al Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol. 2004; 286: H1146-53.
28. Paul RJ, Shull GE, Kranias EG. The sarcoplasmic reticulum and smooth muscle function: evidence from transgenic mice. Novartis Found Symp. 2002; 246:228-38.
29. Martin AF, Bhatti S, Pyne-Geithman GJ, et al Expression and function of COOH-terminal myosin heavy chain isoforms in mouse smooth muscle. Am J Physiol Cell Physiol. 2007; 293: C238-45.
30. Chi M, Zhou Y, Vedamoorthyrao S, et al Ablation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in mice. Proc Natl Acad Sci USA. 2008; 105: 18614-8.
31. Lamounier-Zepter V, Baltas LG, Morano I. Distinct contractile systems for electromechanical and pharmacomechanical coupling in smooth muscle. Adv Exp Med Biol. 2003; 538: 417-25.
32. Babu GJ, Loukianov E, Loukianova T, et al Loss of SM-B myosin affects muscle shortening velocity and maximal force development. Nat Cell Biol. 2001; 3: 1025-9.
33. Hypolite JA, Chang S, LaBelle E, et al Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle. Am J Physiol Renal Physiol. 2009; 296: F658-65.
34. He WQ, Peng YJ, Zhang WC, et al Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology. 2008; 135: 610-20.
35. Isotani E, Zhi G, Lau KS, et al Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proc Natl Acad Sci USA. 2004; 101: 6279-84.
36. Ding HL, Ryder JW, Stull JT, et al Signaling processes for initiating smooth muscle contraction upon neural stimulation. J Biol Chem. 2009; 284: 15541-8.
37. Kojima M, Inui E, Ochiai A, et al Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction. J Urol. 1997; 158: 89-93.
38. Sullivan MP, Yalla SV. Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. J Urol. 1996; 155: 1995-2000.
39. Hoshijima M, Chien KR. Mixed signals in heart failure: cancer rules. J Clin Invest. 2002; 109: 849-55.
40. Chien KR, Olson EN, Hoshijima M. Converging pathways and principles in heart development and disease: CV@CSH. Cell. 2002; 110: 153-62.
41. Chien KR. The molecular basis of congestive heart failure. In: Braunwald E, editor. The molecular basis of cardiovascular disease (Chien, KR, ed): a companion to heart disease. Philadelphia : W.B. Saunders, 2005. p. 637.
42. Kojima M, Inui E, Ochiai A, et al Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction. J Urol. 1997; 158: 89-93.
43. McGuire EJ. Detrusor response to outlet obstruction. Department of Health and Human Services Monograph ; 1987. p. 227.
44. Burkhard FC, Lemack GE, Zimmern PE, et al Contractile protein expression in bladder smooth muscle is a marker of phenotypic modulation after outlet obstruction in the rabbit model. J Urol. 2001; 165: 963-7.
45. Levin RM, High J, Wein AJ. The effect of short-term obstruction on urinary bladder function in the rabbit. J Urol. 1984; 132: 789-91.
46. Austin JC, Chacko SK, DiSanto M, et al A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and Myosin isoform expression. J Urol. 2004; 172: 1524-8.
47. Adam RM, Eaton SH, Estrada C, et al Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells. Physiol Genom. 2004; 20: 36-44.
48. Arafat HA, Kim GS, DiSanto ME, et al Heterogeneity of bladder myocytes in vitro: modulation of myosin isoform expression. Tissue Cell. 2001; 33: 219-32.
49. Zheng Y, Weber WT, Wang S, et al Generation of a cell line with smooth muscle phenotype from hypertrophied urinary bladder. Am J Physiol Cell Physiol. 2002; 283: C373-82.
50. Stein R, Gong C, Hutcheson J, et al The fate of urinary bladder smooth muscle after outlet obstruction-a role for the sarcoplasmic reticulum. Adv Exp Med Biol. 2003; 539: 773-90.
51. Koff SA, Mutabagani KH, Jayanthi VR. The valve bladder syndrome: pathophysiology and treatment with nocturnal bladder emptying. J Urol. 2002; 167: 291-7.
52. Nguyen MT, Pavlock CL, Zderic SA, et al Overnight catheter drainage in children with poorly compliant bladders improves post-obstructive diuresis and urinary incontinence. J Urol. 2005; 174: 1633-6.
53. Stein R, Hutcheson JC, Krasnopolsky L, et al The decompensated detrusor V: molecular correlates of bladder function after reversal of experimental outlet obstruction. J Urol. 2001; 166: 651-7.
54. Su X, Stein R, Stanton MC, et al Effect of partial outlet obstruction on rabbit urinary bladder smooth muscle function. Am J Physiol Renal Physiol. 2003; 284: F644-52.
55. Mannikarottu AS, Hypolite JA, Zderic SA, et al Regional alterations in the expression of smooth muscle myosin isoforms in response to partial bladder outlet obstruction. J Urol. 2005; 173: 302-8.
56. Ratz PH, Hai CM, Murphy RA. Dependence of stress on cross-bridge phosphorylation in vascular smooth muscle. Am J Physiol. 1989; 256: C96-100.
57. Rembold CM, Murphy RA. Myoplasmic calcium, myosin phosphorylation, and regulation of the crossbridge cycle in swine arterial smooth muscle. Circ Res. 1986; 58: 803-15.
58. Cher ML, Abernathy BB, McConnell JD, et al Smooth-muscle myosin heavy-chain isoform expression in bladder-outlet obstruction. World J Urol. 1996; 14: 295-300.
59. 2+ sensitivity of force, but not of MLC phosphorylation, in bladder smooth muscle. Am J Physiol Renal Physiol. 2003; 285: F703-10.
60. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003; 83: 1325-58.
61. Bing W, Chang S, Hypolite JA, et al Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol. 2003; 285: F990-7.
62. MacDonald JA, Borman MA, Muranyi A, et al Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA. 2001; 98: 2419-24.
63. Guven A, Lin WY, Neuman P, et al Effect of age on the role of Rho-kinase in short-term partial bladder outlet obstruction. Urology. 2008; 71: 541-5.
64. Wang T, Kendig DM, Smolock EM, et al Carbachol-induced rabbit bladder smooth muscle contraction: roles of protein kinase C and Rho kinase. Am J Physiol Renal Physiol. 2009; 297: F1534-42.
65. Chang S, Hypolite JA, Mohanan S, et al Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab Invest. 2009; 89: 823-32.
66. Wang ZE, Gopalakurup SK, Levin RM, et al Expression of smooth muscle myosin isoforms in urinary bladder smooth muscle during hypertrophy and regression. Lab Invest. 1995; 73: 244-51.
67. DiSanto ME, Stein R, Chang S, et al Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol. 2003; 285: C1397-410.
68. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2002; 109: S67-79.
69. Clement M, Delaney DP, Austin JC, et al Activation of the calcineurin pathway is associated with detrusor decompensation: a potential therapeutic target. J Urol. 2006; 176: 1225-9.
70. Babij P, Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J Mol Biol. 1989; 210: 673-9.
71. Babij P. Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain. Nucleic Acids Res. 1993; 21: 1467-71.
72. Eddinger TJ, Meer DP. Single rabbit stomach smooth muscle cell myosin heavy chain SMB expression and shortening velocity. Am J Physiol Cell Physiol. 2001; 280: C309-16.
73. Kornblihtt AR. Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol. 2006; 13: 5-7.
74. Kornblihtt AR, de la Mata M, Fededa JP, et al Multiple links between transcription and splicing. RNA. 2004; 10: 1489-98.
75. Wang CL. Caldesmon and the regulation of cytoskeletal functions. Adv Exp Med Biol. 2008; 644: 250-72.
76. Zhang EY, Stein R, Chang S, et al Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol. 2004; 164: 601-12.
77. Matsumoto S, Hanai T, Ohnishi N, et al Bladder smooth muscle cell phenotypic changes and implication of expression of contractile proteins (especially caldesmon) in rats after partial outlet obstruction. Int J Urol. 2003; 10: 339-45.
78. Shukla AR, Nguyen T, Zheng Y, et al Over expression of smooth muscle specific caldesmon by transfection and intermittent agonist induced contraction alters cellular morphology and restores differentiated smooth muscle phenotype. J Urol. 2004; 171: 1949-54.
79. Deng M, Mohanan S, Polyak E, et al Caldesmon is necessary for maintaining the actin and intermediate filaments in cultured bladder smooth muscle cells. Cell Motil Cytoskeleton. 2007; 64: 951-65.
80. Babu GJ, Pyne GJ, Zhou Y, et al Isoform switching from SM-B to SM-A myosin results in decreased contractility and altered expression of thin filament regulatory proteins. Am J Physiol Cell Physiol. 2004; 287: C723-9.
81. Guo H, Wang CL. Specific disruption of smooth muscle caldesmon expression in mice. Biochem Biophys Res Commun. 2005; 330: 1132-7.
82. Mannikarottu AS, Disanto ME, Zderic SA, et al Altered expression of thin filament-associated proteins in hypertrophied urinary bladder smooth muscle. Neurourol Urodyn. 2006; 25: 78-88.
83. Matthew JD, Khromov AS, McDuffie MJ, et al Contractile properties and proteins of smooth muscles of a calponin knockout mouse. J Physiol. 2000; 529: 811-24.
84. Babu GJ, Celia G, Rhee AY, et al Effects of h1-calponin ablation on the contractile properties of bladder versus vascular smooth muscle in mice lacking SM-B myosin. J Physiol. 2006; 577: 1033-42.
85. Wei W, Howard PS, Zderic SA, et al Beta and gamma-sarcoglycans are decreased in the detrusor smooth muscle cells of the partially obstructed rabbit bladder. J Urol. 2008; 179: 2052-6.
86. Macarak EJ, Schulz J, Zderic SA, et al Smooth muscle trans-membrane sarcoglycan complex in partial bladder outlet obstruction. Histochem Cell Biol. 2006; 126: 71-82.